|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Product | |||||
| Royalty and licensing | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income and expenses | |||||
| Interest income | |||||
| Interest expense | |||||
| Foreign currency exchange transaction loss | |||||
| Other income | |||||
| Total other (loss) income | |||||
| Loss before income taxes | |||||
| Income tax (benefit) provision | |||||
| Net loss | |||||
| Weighted average common shares outstanding - basic and diluted (in shares) | |||||
| Net loss per share - basic (in usd per share) | |||||
| Net loss per share - diluted (in usd per share) | |||||
| Weighted average common shares outstanding - basic (in shares) | |||||
| Weighted average common shares outstanding - diluted (in shares) | |||||
Loading...